ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 2888

$1.35M Total Retail Price of All Prescriptions

Rank: 94 out of 2888

697 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 697 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,383 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 654 331 S3 1 4
SIMVASTATIN 640 448 2 2
METFORMIN HCL 611 422 3 8
AMLODIPINE BESYLATE 582 434 4 5
LEVOTHYROXINE SODIUM 577 439 5 1
ATORVASTATIN CALCIUM 536 410 6 9
OMEPRAZOLE 473 307 7 7
FUROSEMIDE 391 262 8 6
CRESTOR 388 246 9 20
METOPROLOL TARTRATE 332 257 10 10
LISINOPRIL 315 223 11 3
NEXIUM 313 195 12 19
GABAPENTIN 297 175 13 13
ZOLPIDEM TARTRATE 287 131 14 17
MELOXICAM 269 206 15 31
TRAMADOL HCL 262 123 16 16
TAMSULOSIN HCL 255 217 17 29
NAPROXEN 243 129 18 80
DIOVAN 231 155 19 35
TIZANIDINE HCL 226 110 20 133
METOPROLOL SUCCINATE 210 156 21 11
CYMBALTA 195 50 22 44
HYDROCHLOROTHIAZIDE 194 124 23 15
ALENDRONATE SODIUM 175 158 24 23
LEVOFLOXACIN 172 110 25 57
BENAZEPRIL HCL 166 147 26 77
CARVEDILOL 154 129 27 21
GLIMEPIRIDE 141 92 28 36
IBUPROFEN 135 69 29 87
TRAZODONE HCL 134 69 30 43
GLIPIZIDE 133 119 31 50
AMLODIPINE BESYLATE-BENAZEPRIL 132 104 32 67
VESICARE 125 93 33 154
RANITIDINE HCL 125 103 33 56
CLOPIDOGREL 125 96 33 30
FLUTICASONE PROPIONATE 121 62 36 32
PREDNISONE 119 84 37 42
DONEPEZIL HCL 118 115 38 26
LOSARTAN POTASSIUM 114 75 39 18
PRAVASTATIN SODIUM 114 66 39 12
AMOX TR-POTASSIUM CLAVULANATE 113 65 41 112
ALLOPURINOL 112 111 42 37
PROAIR HFA 108 57 43 71
JANUVIA 107 47 44 48
VENLAFAXINE HCL ER 104 40 45 120
CITALOPRAM HBR 102 79 46 24
RAMIPRIL 97 73 47 73
ESCITALOPRAM OXALATE 96 57 48 62
CLONIDINE HCL 94 52 49 39
POTASSIUM CHLORIDE 93 76 50 14
PANTOPRAZOLE SODIUM 93 81 50 33
ENALAPRIL MALEATE 91 40 52 49
NAMENDA 87 87 53 34
WARFARIN SODIUM 86 69 54 22
NASONEX 85 53 55 168
TRICOR 85 60 55 91
DIOVAN HCT 83 55 57 61
PLAVIX 83 70 57 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 73 57 28
SYMBICORT 81 53 60 142
EXFORGE 78 67 61 159
HYDRALAZINE HCL 77 57 62 59
LOSARTAN-HYDROCHLOROTHIAZIDE 77 57 62 46
AMITRIPTYLINE HCL 76 49 R 64 74
SINGULAIR 75 46 65 85
ADVAIR DISKUS 75 53 65 60
BYSTOLIC 74 39 67 99
LANTUS SOLOSTAR 71 39 68 92
SPIRONOLACTONE 69 40 69 70
LANTUS 69 34 69 45
TERAZOSIN HCL 68 67 71 152
SERTRALINE HCL 68 34 71 27
CIPROFLOXACIN HCL 68 53 71 47
SPIRIVA 67 50 74 79
MECLIZINE HCL 66 43 75 122
FLUOXETINE HCL 66 32 75 83
ESTRADIOL 65 49 R 77 139
DIGOXIN 64 60 78 55
ATENOLOL 61 59 79 25
INSULIN SYRINGE 61 39 79 86
VERAPAMIL ER 59 25 81 104
ZETIA 59 53 81 81
DEXILANT 58 24 83 186
LIPITOR 57 27 84 78
LYRICA 55 21 85 69
PEN NEEDLE 55 19 85 110
LANSOPRAZOLE 54 49 87 213
SEROQUEL XR 53 0 88 271
FINASTERIDE 53 41 88 102
ISOSORBIDE MONONITRATE ER 50 45 90 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.